Dr. Sarah Tabrizi discusses the main findings of her study on targeting Huntington expression in patients with Huntington's Disease. Ready the May 6th article in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa1900907?query=recirc_curatedRelated_article
